Forte Biosciences
FBRX
29 hedge funds and large institutions have $39.3M invested in Forte Biosciences in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
12% more funds holding
Funds holding: 26 → 29 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
60% less capital invested
Capital invested by funds: $97.1M → $39.3M (-$57.8M)
214.08% less ownership
Funds ownership: 292.87% → 78.79% (-214%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$10.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$738K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$510K |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$418K |
| 5 |
Millennium Management
New York
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$2.64M |
| 2 |
PA
Perceptive Advisors
New York
|
-$2.17M |
| 3 |
O
OrbiMed
New York
|
-$81.6K |
| 4 |
JP Morgan Chase
New York
|
-$24.8K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.22K |
FBRX Hedge Fund Activity: Q1 2025 in Review
29 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2025, worth a combined $39.3M — down 60% from $97.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FBRX positions and 2 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $10.9M. The largest seller was Fred Alger Management, cutting an estimated $2.64M.
- 29 institutional investors held Forte Biosciences (FBRX) as of Q1 2025, up from 26 in Q4 2024.
- Funds reported $39.3M of Forte Biosciences stock for Q1 2025, down 60% quarter-over-quarter.
- 5 funds opened new Forte Biosciences positions in Q1 2025 and 2 closed out, a net change of +3 holders.
- The largest Forte Biosciences buyer in Q1 2025 was Janus Henderson Group, an estimated $10.9M added.
- The largest Forte Biosciences seller in Q1 2025 was Fred Alger Management, an estimated $2.64M sold.
Based on aggregated 13F filings for Q1 2025.